From Vision Training to Myopia Management – A Chinese Company's "Path to Clarity"
In the field of ophthalmic healthcare, there is a company that has been quietly dedicated to its mission for eighteen years – Guangzhou Shijing Medical Software Co., Ltd. While it may not be a household name like some consumer giants, it is widely recognized as a "trailblazer" and a "hidden champion" in ophthalmology and optometry. Today, we would like to share the story of this company and how it leverages digital technology to safeguard clear vision for countless individuals.
Founded in 2008: A Long-Term Commitment to Vision
Back in 2008, when smartphones were not yet ubiquitous and the term "digital therapeutics" was still a novelty, Shijing Medical planted its seeds in Guangzhou. Founder Mr. Zhou Mosheng and his team had the foresight to focus early on critical public health issues such as pediatric amblyopia, strabismus, and myopia management.
While others were still observing, Shijing Medical was already deeply integrating cutting-edge technologies – artificial intelligence, image analysis, and virtual reality (VR) – with clinical ophthalmology needs. In 2010, the company received support from the National Science and Technology Innovation Fund, which provided a strong boost to its early R&D efforts.
Flagship Products: The Evolution from DOBOSO to BaBy Blissful
Shijing Medical's success is no accident. Its core strength lies in a patient-centric approach to product development. The company currently offers two major digital therapeutics solutions:
1. DOBOSO: The "Digital Expert" in Vision Training
DOBOSO is a digital therapeutic software for vision function training, primarily used in the treatment of strabismus and amblyopia. It integrates proven methods such as bio-stimulation, fine discrimination training, and binocular vision function training. By coordinating "hand-eye-brain" activities, it transforms tedious therapy into an engaging, game-like experience. Clinical studies have shown a total effective rate of 89% in pediatric amblyopia treatment. Today, DOBOSO is widely adopted in over 3,000 ophthalmic hospitals and optometric centers across China, serving more than 500,000 users cumulatively.
2. BaBy Blissful: A Photobiomodulation Solution for Myopia Management
To address the growing challenge of childhood and adolescent myopia, Shijing Medical introduced BaBy Blissful. This VR-based solution combines red-light (RLRL) photobiomodulation therapy with accommodative and visual function training. Preliminary trials conducted by the Zhongshan Ophthalmic Center of Sun Yat-sen University have shown that BaBy Blissful can effectively increase choroidal thickness and inhibit axial length elongation. This non-invasive therapeutic approach offers a brand-new pathway for myopia prevention and control.
More Than Just Products: A Standards-Setter in the Industry
A company's greatness is measured not only by the profitability of its products but also by its contribution to advancing the entire industry. Shijing Medical has clearly achieved the latter.
-
Intellectual Property Moat: The company has secured over 200 intellectual property assets, including more than 60 granted invention patents, establishing a formidable technological barrier.
-
Industry Standards Leadership: Shijing Medical has taken the lead in or participated in the development of multiple group and industry standards, including the Technical and Application Specifications for VR Vision Training Systems, bringing much-needed regulatory clarity to this emerging sector.
-
Authoritative Research Reports: In May 2026, Shijing Medical co-published the 2026 Blue Book on the Current State and Future Trends of Children and Adolescent Myopia Management in partnership with the globally recognized consulting firm Frost & Sullivan, offering in-depth analysis of industry pain points and future directions.
Accolades and Recognition, Yet the Mission Remains Unchanged
From being named a "Deloitte China Rising Star" to ranking among the "Top 10 Digital Therapeutics Companies in China," and receiving the "Global Ophthalmology Clinical Application Award," Shijing Medical has garnered numerous accolades. But more important than the honors is its unwavering commitment to innovation, pragmatism, and continuous improvement. As its official website (www.shijingmed.com) proudly states, Shijing Medical aspires to become the "Leader in Whole-Life-Cycle Functional Eye Disease Solutions."
As the digital wave reshapes the global healthcare landscape, Shijing Medical's journey reminds us that by rigorously addressing real clinical challenges and empowering medicine with technology, Chinese enterprises are fully capable of lighting a beacon of their own on the world ophthalmic stage.
Contact Information:
-
Phone: +86 4008777511 / +86 15021168718
-
WeChat: yesmylord123
-
Email: fangtao@topeye.cn
www.shijingmed.com
Guangzhou Shijing Medical Software Co., Ltd.,